Sale disclosed
Peter Greenleaf
Director
Common Stock
- Reported value
- $16.87K
- Reported price
- $21.17 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Pelthos Therapeutics Inc.
Last 30 daysNo qualifying insider buying. Sales: $44.94K by 3 insiders.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
CFO, Treas & Secty
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale10b5-1 | 797$21.17 / share | $16.87K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 558$20.72 / share | $11.56K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-1 | 786$21.00 / share | $16.51K | Oct 2Filed Oct 6 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 558avg $26.09 / share | $14.56K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 786avg $26.16 / share | $20.56K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 797avg $26.13 / share | $20.83K | Jul 2Filed Jul 7 · 5d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 283avg $27.29 / share | $7.72K | Jun 15Filed Jun 17 · 2d later | 2 filings
|
| CFO, Treas & Secty | Common StockSale | 1,500$26.84 / share | $40.26K | May 22Filed May 26 · 4d later | SEC filing |
| Director | Common StockSale10b5-12 trades | 590avg $20.92 / share | $12.34K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 558avg $20.92 / share | $11.67K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 786avg $20.92 / share | $16.44K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
| Director | Common StockSale10b5-12 trades | 797avg $20.92 / share | $16.67K | Apr 2Filed Apr 6 · 4d later | 2 filings
|
This reflects the filings imported so far, not a complete trading history.
$249,996 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.